Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.66 $2.47 Friday, 10th May 2024 PTN stock ended at $2.29. This is 2.55% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 11.76% from a day low at $2.21 to a day high of $2.47.
90 days $1.47 $4.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Aug 10, 2016 $0.580 $0.608 $0.562 $0.577 2 454 700
Aug 09, 2016 $0.584 $0.600 $0.560 $0.581 451 800
Aug 08, 2016 $0.560 $0.590 $0.550 $0.570 319 100
Aug 05, 2016 $0.600 $0.610 $0.540 $0.560 1 014 000
Aug 04, 2016 $0.620 $0.660 $0.580 $0.594 1 544 700
Aug 03, 2016 $0.530 $0.580 $0.530 $0.561 564 000
Aug 02, 2016 $0.640 $0.670 $0.520 $0.570 2 375 400
Aug 01, 2016 $0.85 $0.86 $0.680 $0.700 1 246 100
Jul 29, 2016 $0.80 $0.84 $0.80 $0.81 899 900
Jul 28, 2016 $0.720 $0.85 $0.692 $0.799 2 073 400
Jul 27, 2016 $0.665 $0.710 $0.645 $0.700 450 700
Jul 26, 2016 $0.630 $0.670 $0.620 $0.652 524 800
Jul 25, 2016 $0.580 $0.680 $0.574 $0.635 1 326 800
Jul 22, 2016 $0.540 $0.585 $0.535 $0.572 418 100
Jul 21, 2016 $0.531 $0.555 $0.531 $0.540 89 100
Jul 20, 2016 $0.558 $0.558 $0.530 $0.530 151 900
Jul 19, 2016 $0.540 $0.559 $0.530 $0.543 82 300
Jul 18, 2016 $0.530 $0.549 $0.530 $0.540 162 300
Jul 15, 2016 $0.536 $0.545 $0.530 $0.535 99 600
Jul 14, 2016 $0.550 $0.560 $0.530 $0.545 145 700
Jul 13, 2016 $0.550 $0.565 $0.525 $0.550 223 400
Jul 12, 2016 $0.520 $0.560 $0.520 $0.550 413 600
Jul 11, 2016 $0.520 $0.538 $0.520 $0.532 167 200
Jul 08, 2016 $0.521 $0.530 $0.500 $0.510 338 100
Jul 07, 2016 $0.523 $0.550 $0.502 $0.530 121 800
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT